Clinical results of radiation therapy for stage I esophageal cancer: A single institutional experience

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 1, 2005, Pages 75-80

  Shioyama, Yoshiyuki ^a   Nakamura, Katsumasa ^a   Sasaki, Tomonari ^a   Ooga, Saiji ^a   Urashima, Yusuke ^a   Kimura, Masahiko ^b   Uehara, Satoru ^c   Terashima, Hiromi ^d   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b ASO IIZUKA HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Radiation therapy; Stage I esophageal cancer

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS ULCER; FEMALE; HUMAN; LEUKOPENIA; LUNG TOXICITY; LYMPH NODE METASTASIS; MALE; MEDIASTINUM METASTASIS; OUTCOMES RESEARCH; PERICARDIAL EFFUSION; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; SKIN MANIFESTATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 13444260748     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000139021.91718.ee     Document Type: Article

References (23)

1. Iizuka T, Isono K, Kakegawa T, et al. Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Chest. 1989;96:1007-1011.
2. Nabeya K, Nakata Y. Extent of resection and lymphadenectomy in early squamous cell esophageal cancer. Dis Esophagus. 1997;10:159-161.
3. Kodama M, Kakegawa T. Treatment of superficial esophageal cancer of the esophagus: a summary of response to a questionnaire on superficial cancer of the esophagus in Japan. Surgery. 1998;123:432-439.
4. Okawa T, Tanaka M, Kita M, et al. Radiotherapy for superficial esophageal cancer. Int J Radiat Oncol Biol Phys. 1994;30:959-964.
5. Okawa T, Tanaka M, Okawa MK, et al. Superficial esophageal cancer: multi-center analysis of results of definitive radiation therapy in Japan. Radiology. 1995;196:271-274.
6. Okawa T, Dokiya T, Nishio M, et al. Multi-institutional randomized trial of radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Int J Radiat Oncol Biol Phys. 1999;45:623-628.
7. Akagi Y, Hirokawa Y, Kagemoto M, et al. Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external irradiation of early stage esophageal cancer. Int J Radiat Oncol Biol Phys. 1999;43:525-530.
8. Nishimura Y, Okuno Y, Ono K, et al. External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma. Cancer. 1999;15:220-228.
9. Maingon P, D'Hombres A, Truc G, et al. High dose rate brachytherapy for superficial cancer of the esophagus. Int J Radiat Oncol Biol Phys. 2000;46:71-76.
10. Nemoto K, Matsumoto Y, Yamakawa M, et al. Treatment of superficial esophageal cancer by external radiation therapy alone: results of multiinstitutional experiences. Int J Radiat Oncol Biol Phys. 2000;46:921-925.
11. Nemoto K, Yamada S, Hareyama M, et al. Radiation therapy for superficial esophageal cancer: a comparison of radiotherapy methods. Int J Radiat Oncol Biol Phys. 2001;50:639-644.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
13. Isono K, Sano H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology. 1991;48:411-420.
14. Kato H, Tachimori Y, Watanabe H, et al. Superficial esophageal carcinoma. Surgical treatment and the results. Cancer. 1990;66:2319-2323.
15. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593-1598.
16. Sakai K, Inakoshi H, Sueyama, et al. Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fuluorouracil in inoperable esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 1995;31:921-927.
17. Smith TJ, Ryan LM, Douglass HO, et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the eastern cooperative oncology group. Int J Radiat Oncol Biol Phys. 1998;42:269-276.
18. Nishimaki T, Tanaka O, Suzuki T, et al. Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment. World J Surg. 1993;17:766-771.
19. Luketich JD, Schauer PR, Meltzer CC, et al. Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg. 1997;64:765-769.
20. Block MI, Patterson GA, Sundaresan RS, et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg. 1997;64:770-776.
21. Meltzer CC, Luketich JD, Friedman D, et al. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin Nucl Med. 2000;25:882-887.
22. Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol. 2000;18:3202-3210.
23. Choi JY, Lee KH, Shim YM, et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med. 2000;41:808-815.